Nomir Medical Announces 510(k) Application to FDA for the Temporary Increase of Clear Nail in Patients With Onychomycosis (Toenail Fungus) With the Noveon™ Laser  
9/5/2012 10:30:15 AM

WOODMERE, N.Y.--(BUSINESS WIRE)--Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that the company has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for the indication of temporary increase of clear nail in patients with onychomycosis (toenail fungus).